All regulatory updates
718 results found
POPRC-22 scheduled for 21–25 September 2026 in Rome; revised draft risk profile for PBDD/Fs and mixed PBDD/PCDD/Fs to be considered
The Stockholm Convention Secretariat meeting page indicates that POPRC-22 is scheduled in Rome, Italy (21–25 September 2026) and will consider a revised draft risk profile for polybrominated dibenzo-p-dioxins and dibenzofurans (PBDD/Fs) and mixed polybrominated/chlorinated dibenzo-p-dioxins and dibenzofurans (mixed PBDD/PCDD/Fs). The page also notes POPRC-21 deferred its decision and invited additional Annex E information. For compliance monitoring, this is a process signal that these substances remain under active evaluation and could lead to future listing recommendations to the COP.
Stockholm Convention POPRC-22 meeting details published (21–25 September 2026, Rome) including revised draft risk profile item for PBDD/Fs and mixed PBDD/PCDD/Fs
The Stockholm Convention Secretariat published the official schedule and key agenda focus for the 22nd meeting of the Persistent Organic Pollutants Review Committee (POPRC-22), to be held 21–25 September 2026 in Rome, Italy (FAO HQ). The posted overview highlights that POPRC will consider the revised draft risk profile for polybrominated dibenzo-p-dioxins and dibenzofurans (PBDD/Fs) and mixed polybrominated/chlorinated dibenzo-p-dioxins and dibenzofurans, including requests for additional Annex E information. This is relevant to regulatory horizon-scanning because POPRC outcomes can advance candidate chemicals through the Article 8 process toward possible future listing decisions by the COP.
Louisiana Board of Pharmacy opens Regulatory Project 2026-01 to overhaul Controlled Dangerous Substances rules (Chapter 27), including ARCOS reports only upon request
The Louisiana Board of Pharmacy (LABP) lists an active rulemaking project (Regulatory Project 2026-01) to amend LAC Title 46, Part LIII, Chapter 27 (Controlled Dangerous Substances). The stated intent includes adopting federal controlled substance regulations by reference, consolidating Louisiana-specific provisions into §2713, repealing redundant sections, and changing distributor reporting so ARCOS-related reports would be provided to the Board only upon request (reducing routine reporting burden). Compliance teams supporting CDS registrants (manufacturers, distributors, pharmacies, etc.) should track this project because it may materially change Louisiana-specific procedural obligations and the frequency/trigger for ARCOS data submissions to the state regulator.
AICIS opens public comment on 11 draft evaluation statements (comments due 28 May 2026)
AICIS opened a consultation inviting public comment on 11 draft evaluation statements. These draft evaluations can inform future risk management recommendations and compliance expectations for introducers. The comment period closes at 11:59pm AEST on 28 May 2026.
EU Packaging and Packaging Waste Regulation — application begins 12 August 2026
The European Union has introduced updates under the Packaging and Packaging Waste framework to strengthen requirements on packaging sustainability, waste reduction, and recyclability. The regulation sets stricter obligations on the use, design, labeling, and disposal of packaging materials across the EU market. It aims to reduce environmental impact by promoting circular economy principles, including increased recyclability, reuse targets, and reduction of hazardous substances in packaging. General application begins: 12 August 2026. Key Requirements: • Mandatory recyclability and reusability targets for packaging • Reduction of excess and unnecessary packaging • Restrictions on hazardous substances in packaging materials • Introduction of labeling and information requirements • Increased responsibility under Extended Producer Responsibility (EPR)
ASTM opens WK86336 work item to revise A193/A193M-23 (remove duplicate/conflicting Grade B8 row in Table 2)
ASTM has an active work item (WK86336) proposing a revision to ASTM A193/A193M-23 to correct an identified inconsistency in Table 2 (austenitic steels). The work item indicates Grade B8 should be removed from a duplicate/conflicting “Class 1 and 1D” row because the two rows have different elongation requirements, creating ambiguity. Compliance/procurement/specification teams that rely on A193/A193M-23 (including for Grade B8 bolting acceptance criteria) should monitor this work item and be prepared to update internal specifications, purchase orders, and inspection/test criteria once the revision is balloted and published as a new edition or correction.
Gunnison requires a city business license beginning Jan 1, 2026; city sales tax licensing/collection shifts to Colorado DOR; 2026 grace period through March 31, 2026
The City of Gunnison’s official business licensing portal describes a new requirement for businesses operating within Gunnison city limits to obtain a City of Gunnison Business License starting January 1, 2026 (noting a $20 fee and applicability to various business types). The city also indicates changes to sales tax administration starting January 1, 2026 (city sales tax licensing/collection shifting to state administration) and that vendor fees will no longer be offered beginning in 2026. For vendor onboarding and ongoing compliance, this creates a new/changed local registration requirement (business license) and alters the sales-tax registration/remittance workflow. The city provides a 2026-only grace period allowing businesses to obtain an active 2026 license through March 31, 2026.
EPA issues proposed TSCA SNURs for certain chemical substances (26–2); comments due May 26, 2026
EPA issued a proposed rule to add Significant New Use Rules (SNURs) for certain chemical substances subject to TSCA consent orders. The proposal would require companies to submit a Significant New Use Notice (SNUN) at least 90 days before manufacturing or processing for a designated significant new use. Compliance teams should identify whether any affected substances are in their portfolios and consider commenting by the deadline; if finalized, SNUN planning/lead times and use restrictions may affect R&D, scale-up, importing, and downstream customer applications.
EPA issues project-specific BABA nonavailability waiver decision memo for point-of-use reverse osmosis treatment units (City of Iuka, KS)
EPA posted an approved, project-specific nonavailability waiver under BABA for a drinking water project (City of Iuka, Kansas). The decision memo documents EPA’s determination that compliant domestic products were not available to meet project technical specifications, allowing procurement/use of non-BABA-compliant point-of-use reverse osmosis treatment units for that project only. Compliance teams supporting EPA-funded water infrastructure should track this waiver as it illustrates required waiver justification elements and reinforces that such waivers are limited in scope to the named project and timeframe stated in the decision memo.
ESAs Joint Committee Annual Report 2025 published summarizing DORA CTPP designation and oversight readiness (JETs/fees)
The Joint Committee of the European Supervisory Authorities published its Annual Report 2025, which includes updates on implementation of DORA’s oversight regime for critical ICT third‑party providers (CTPPs). The report describes the ESAs’ work on the CTPP designation process and oversight preparations (e.g., Joint Examination Teams and oversight fee readiness). This is not a new binding rule, but it is an authoritative regulator publication that informs financial entities’ and ICT vendors’ expectations for DORA third‑party oversight, contracting, resilience testing, and supervisory engagement.
RMI FAQ clarifies companies generally do not need to re-survey suppliers solely because a new CMRT is released in April
RMI published/maintains official downstream FAQ guidance stating that when RMI releases a new CMRT in April, companies generally should not re-survey suppliers specifically to force use of the new version for the upcoming filing. RMI indicates the April CMRT update is intended for the next year’s filing cycle; companies should use the most recent version available at the time they initiate their annual supplier survey and clearly state which CMRT version was used/accepted. Compliance teams using CMRT for supplier data collection should align annual survey timing and version-control statements accordingly to avoid unnecessary rework and to maintain auditable documentation of the template version relied upon.
Louisiana Board of Pharmacy lists 2026-A legislative proposal for CDS schedules update to mirror federal scheduling actions
The Louisiana Board of Pharmacy’s legislative proposals page includes a 2026 proposal titled '2026-A – CDS Schedules Update,' described as updating Louisiana controlled dangerous substances schedules to mirror federal scheduling actions. This is an early policy signal (not an enacted change) that may lead to future UCDSL scheduling updates. Compliance teams should monitor for subsequent bill introductions or rulemaking that would add/remove/reclassify controlled substances in Louisiana schedules.
European Commission CRA implementation factpage updated to track deliverables and link the implementing act defining technical descriptions for important/critical product categories
The European Commission updated its CRA implementation factpage (shown as last updated 23 April 2026). The page tracks CRA implementation deliverables and explicitly points implementers to the Commission implementing act that specifies the technical descriptions of categories of ‘important’ and ‘critical’ products with digital elements. For CRA Annex IV (critical products), this matters because the technical descriptions are used for scoping/classification decisions that drive the applicable conformity assessment route (including when third-party involvement is required).
Illinois HB4834 proposes removing testosterone and specified reproductive-health drugs from Prescription Monitoring Program (PMP) reporting and requires purge of existing testosterone PMP records by Jan 1, 2027
HB4834 proposes amendments to the Illinois Controlled Substances Act’s Prescription Monitoring Program provisions (720 ILCS 570/316) to exclude testosterone and certain specified drugs (including mifepristone, misoprostol, GnRH analogues, and estrogen) from PMP applicability as described in the research text. It would also add a new Section 316.2 requiring the Department to purge existing PMP records concerning testosterone by 2027-01-01 and ensure no further testosterone records are created/maintained, with associated rules updates by 2027-01-01. If enacted, this would change PMP reporting scope, downstream analytics, and record retention/purge obligations for covered entities and the administering Department; compliance teams should monitor bill status and assess impacts to PMP submission and data governance processes.
ECHA Candidate List table dataset will be maintained until July 2026 during transition to ECHA CHEM
ECHA’s Candidate List table page notes that Candidate List regulatory information is available in the new ECHA CHEM database and that ECHA will keep the legacy Candidate List table dataset up to date “until July 2026” to support a smooth transition. Compliance teams should plan to migrate SVHC Candidate List monitoring and evidence workflows to ECHA CHEM while ensuring any internal tooling that relies on the legacy table continues to function during the transition period.
Louisiana HB 568 (2026 Regular Session) proposes changes to drug-free school zone penalty enhancement provisions in R.S. 40:981.3
HB 568 (2026 Regular Session) proposes amendments to R.S. 40:981.3 (drug free zone enhancements for Uniform Controlled Dangerous Substances Law violations). The engrossed bill would amend and reenact R.S. 40:981.3(D) and enact additional provisions (including a new subsection addressing controlled dangerous substance violations while smoking/vaping/otherwise abusing a substance on school property/within 2,000 feet/on a school bus) and a penalty carve-out for conduct also constituting a marijuana-related violation under R.S. 40:966(C)(2). Compliance teams should monitor because drug-free-zone enhancement rules can affect criminal exposure and enforcement posture for activities involving controlled substances near schools and school buses.
POPRC.22 meeting overview published (Rome, 21–25 September 2026)
The Stockholm Convention published the meeting overview page for the twenty-second meeting of the Persistent Organic Pollutants Review Committee (POPRC.22), scheduled for 21–25 September 2026 in Rome. While not a binding legal amendment, publication of the official meeting page signals active review activity (including consideration of revised draft risk profiles) that can lead to future POP listing recommendations. Compliance teams may use this to anticipate upcoming scientific/regulatory evaluations and potential future controls.
AICIS preview: upcoming 2026 Categorisation Guidelines changes (high-hazard list updates and other guideline revisions)
AICIS published a preview of upcoming changes to the 2026 Industrial Chemicals Categorisation Guidelines, including updates to the list of chemicals with high hazards for categorisation (new entries and updates to existing entries) and other guideline changes (as described on the preview page). Compliance impact: introducers should monitor and prepare for guideline revisions affecting categorisation decisions and potential eligibility for exempted/reported pathways, and review whether any introduced chemicals will fall into newly added or updated high-hazard entries once the updated guidelines apply.
AICIS invites public comment on 11 draft evaluation statements (117 chemicals) including proposed AIIC listing variations for retinol/esters, 2‑pyrrolidinone and 4‑phenylbenzophenone
AICIS opened public comment on 11 draft evaluation statements covering 117 chemicals. The consultation notes that three draft evaluations propose variations to AIIC listing terms under Industrial Chemicals Act 2019 s86: (1) Retinol and retinol esters (EVA00187), (2) 2‑Pyrrolidinone (EVA00193), and (3) 4‑Phenylbenzophenone (EVA00201). Compliance impact: companies introducing these substances (and any within the evaluated group) should review the draft evaluations for potential upcoming listing-term changes (e.g., additional conditions, risk-management measures, or information requirements) and submit comments before the stated close date (28 May 2026).
ASTM opens WK86336 work item to revise A193/A193M-23 (remove duplicate/conflicting Grade B8 row in Table 2)
ASTM International has an active standards-development work item (WK86336) to revise ASTM A193/A193M-23. The stated rationale is to remove Grade B8 from a duplicate/conflicting 'Class 1 and 1D' row in Table 2 (austenitic steels section), because Grade B8 is listed twice with different elongation requirements. While ASTM standards are voluntary, this type of revision can become compliance-relevant where A193/A193M is incorporated by reference into codes/regulations or contract specifications; compliance teams should monitor publication of the next revision and assess impacts on procurement specifications, material certification review, and acceptance criteria for Grade B8 bolting materials.